• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical cancer research--some aspects on doctors' attitudes to informing participants.

作者信息

Lynöe N, Sandlund M, Jacobsson L

机构信息

Department of Social Medicine, Umeå University, Sweden.

出版信息

Acta Oncol. 1996;35(6):749-54. doi: 10.3109/02841869609084010.

DOI:10.3109/02841869609084010
PMID:8938225
Abstract

With the aim to investigate the information policy of oncologists when recruiting patients for clinical trials a postal questionnaire was sent to 412 members of the Swedish Society of Oncology (response rate 74%). Depending on the situation, 20-40% of the doctors perceive that randomization before consent is an acceptable procedure. A majority of the physicians maintain that cancer patients are able to cope with adequate information but 45% of the doctors fear that the patients may withdraw from participating if they are adequately informed. It seems to be important to study the relationship between the quality of information given to participants and the motives they have for accepting or declining to participate.

摘要

相似文献

1
Clinical cancer research--some aspects on doctors' attitudes to informing participants.
Acta Oncol. 1996;35(6):749-54. doi: 10.3109/02841869609084010.
2
Financial ties as part of informed consent to postmarketing research. Attitudes of American doctors and patients.作为上市后研究知情同意一部分的经济关联。美国医生和患者的态度。
BMJ. 1995 Jun 24;310(6995):1660-3. doi: 10.1136/bmj.310.6995.1660.
3
Informed consent: study of quality of information given to participants in a clinical trial.知情同意:关于向临床试验参与者提供的信息质量的研究。
BMJ. 1991 Sep 14;303(6803):610-3. doi: 10.1136/bmj.303.6803.610.
4
Perceptions of cancer patients and their physicians involved in phase I trials.参与I期试验的癌症患者及其医生的看法。
J Clin Oncol. 1995 May;13(5):1062-72. doi: 10.1200/JCO.1995.13.5.1062.
5
Phase I cancer trials. A collusion of misunderstanding.I期癌症试验。误解的交织。
Hastings Cent Rep. 2000 Jul-Aug;30(4):34-43.
6
Patients' perceptions on informed consent and the quality of information disclosure in clinical trials.患者对临床试验中知情同意和信息披露质量的看法。
Patient Educ Couns. 1996 Nov;29(2):137-53. doi: 10.1016/0738-3991(96)00859-2.
7
Information in the ICU: are we being honest with our patients? The results of a European questionnaire.重症监护病房中的信息:我们是否对患者坦诚相待?一项欧洲问卷调查的结果。
Intensive Care Med. 1998 Dec;24(12):1251-6. doi: 10.1007/s001340050758.
8
Developing ethical strategies to assist oncologists in seeking informed consent to cancer clinical trials.制定伦理策略,以协助肿瘤学家在癌症临床试验中寻求知情同意。
Soc Sci Med. 2004 Jan;58(2):379-90. doi: 10.1016/s0277-9536(03)00204-1.
9
Ethical aspects of clinical trials: the attitudes of the public and out-patients.临床试验的伦理问题:公众和门诊患者的态度
J Intern Med. 1999 Jun;245(6):571-9. doi: 10.1046/j.1365-2796.1999.00502.x.
10
Must research participants understand randomization?研究参与者必须理解随机分组吗?
Am J Bioeth. 2009 Feb;9(2):3-8. doi: 10.1080/15265160802654145.

引用本文的文献

1
The definition of placebo in the informed consent forms of clinical trials.临床试验知情同意书中安慰剂的定义。
PLoS One. 2014 Nov 25;9(11):e113654. doi: 10.1371/journal.pone.0113654. eCollection 2014.
2
Satisfaction with the decision to participate in cancer clinical trials is high, but understanding is a problem.患者对参与癌症临床试验的决策满意度较高,但理解存在问题。
Support Care Cancer. 2011 Mar;19(3):371-9. doi: 10.1007/s00520-010-0829-6. Epub 2010 Feb 23.